308 related articles for article (PubMed ID: 19477198)
21. 3-Alkyl- and 3-aryl-7H-furo[3,2-g]chromen-7-ones as blockers of the voltage-gated potassium channel Kv1.3.
Wernekenschnieder A; Körner P; Hänsel W
Pharmazie; 2004 Apr; 59(4):319-20. PubMed ID: 15125582
[TBL] [Abstract][Full Text] [Related]
22. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
[TBL] [Abstract][Full Text] [Related]
23. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
[TBL] [Abstract][Full Text] [Related]
24. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.
Toldi G; Vásárhelyi B; Kaposi A; Mészáros G; Pánczél P; Hosszufalusi N; Tulassay T; Treszl A
Immunol Lett; 2010 Sep; 133(1):35-41. PubMed ID: 20603149
[TBL] [Abstract][Full Text] [Related]
25. Kv1.3 Current Voltage Dependence in Lymphocytes is Modulated by Co-Culture with Bone Marrow-Derived Stromal Cells: B and T Cells Respond Differentially.
Valle-Reyes S; Dobrovinskaya O; Pottosin I
Cell Physiol Biochem; 2020 Sep; 54(5):842-852. PubMed ID: 32886870
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the K+ current in human CD4+ T lymphocytes in hypercholesterolemic state.
Somodi S; Balajthy A; Szilágyi O; Pethő Z; Harangi M; Paragh G; Panyi G; Hajdu P
Cell Immunol; 2013 Jan; 281(1):20-6. PubMed ID: 23416720
[TBL] [Abstract][Full Text] [Related]
27. Modulation of voltage-gated potassium channels in human T lymphocytes by extracellular glutamate.
Poulopoulou C; Markakis I; Davaki P; Nikolaou C; Poulopoulos A; Raptis E; Vassilopoulos D
Mol Pharmacol; 2005 Mar; 67(3):856-67. PubMed ID: 15718225
[TBL] [Abstract][Full Text] [Related]
28. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.
Koo GC; Blake JT; Talento A; Nguyen M; Lin S; Sirotina A; Shah K; Mulvany K; Hora D; Cunningham P; Wunderler DL; McManus OB; Slaughter R; Bugianesi R; Felix J; Garcia M; Williamson J; Kaczorowski G; Sigal NH; Springer MS; Feeney W
J Immunol; 1997 Jun; 158(11):5120-8. PubMed ID: 9164927
[TBL] [Abstract][Full Text] [Related]
29. Influence of the multidrug transporter inhibitors on the activity of Kv1.3 voltage-gated potassium channels.
Teisseyre A; Duarte N; Ferreira MJ; Michalak K
J Physiol Pharmacol; 2009 Mar; 60(1):69-76. PubMed ID: 19439809
[TBL] [Abstract][Full Text] [Related]
30. Slowing of the inactivation of voltage-dependent sodium channels by staurosporine, the protein kinase C inhibitor, in rabbit atrial myocytes.
Ko JH; Park WS; Kim SJ; Earm YE
Eur J Pharmacol; 2006 Mar; 534(1-3):48-54. PubMed ID: 16488408
[TBL] [Abstract][Full Text] [Related]
31. Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3.
Rauer H; Grissmer S
Mol Pharmacol; 1996 Dec; 50(6):1625-34. PubMed ID: 8967986
[TBL] [Abstract][Full Text] [Related]
32. High extracellular potassium ion concentration attenuates the blockade action of ketanserin on Kv1.3 channels expressed in xenopus oocytes.
Liang ZT; Wang XP; Zeng QT; Liao YH; Zou AR; Li L; Tu DN
Chin Med J (Engl); 2008 Dec; 121(24):2584-91. PubMed ID: 19187600
[TBL] [Abstract][Full Text] [Related]
33. Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.
Arias C; Guizy M; David M; Marzian S; González T; Decher N; Valenzuela C
Anesthesiology; 2007 Oct; 107(4):641-51. PubMed ID: 17893461
[TBL] [Abstract][Full Text] [Related]
34. Elementary properties of Kir2.1, a strong inwardly rectifying K(+) channel expressed by pigeon vestibular type II hair cells.
Zampini V; Masetto S; Correia MJ
Neuroscience; 2008 Sep; 155(4):1250-61. PubMed ID: 18652879
[TBL] [Abstract][Full Text] [Related]
35. A structural link between inactivation and block of a K+ channel.
Ader C; Schneider R; Hornig S; Velisetty P; Wilson EM; Lange A; Giller K; Ohmert I; Martin-Eauclaire MF; Trauner D; Becker S; Pongs O; Baldus M
Nat Struct Mol Biol; 2008 Jun; 15(6):605-12. PubMed ID: 18488040
[TBL] [Abstract][Full Text] [Related]
36. The inhibitory effect of copper ions on lymphocyte Kv1.3 potassium channels.
Teisseyre A; Mozrzymas JW
J Physiol Pharmacol; 2006 Jun; 57(2):301-14. PubMed ID: 16845233
[TBL] [Abstract][Full Text] [Related]
37. Short- and long-term amiodarone treatments regulate Cav3.2 low-voltage-activated T-type Ca2+ channel through distinct mechanisms.
Yamashita N; Kaku T; Uchino T; Isomoto S; Yoshimatsu H; Ono K
Mol Pharmacol; 2006 May; 69(5):1684-91. PubMed ID: 16443692
[TBL] [Abstract][Full Text] [Related]
38. The sensitivity of the human Kv1.3 (hKv1.3) lymphocyte K+ channel to regulation by PKA and PKC is partially lost in HEK 293 host cells.
Martel J; Dupuis G; Deschênes P; Payet MD
J Membr Biol; 1998 Jan; 161(2):183-96. PubMed ID: 9435274
[TBL] [Abstract][Full Text] [Related]
39. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.
Varga Z; Csepany T; Papp F; Fabian A; Gogolak P; Toth A; Panyi G
Immunol Lett; 2009 Jun; 124(2):95-101. PubMed ID: 19409928
[TBL] [Abstract][Full Text] [Related]
40. Gating of the expressed T-type Cav3.1 calcium channels is modulated by Ca2+.
Lacinová L; Kurejová M; Klugbauer N; Hofmann F
Acta Physiol (Oxf); 2006 Apr; 186(4):249-60. PubMed ID: 16634780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
